FDA designates Class I recall for mobile lift component

Editor's Note

The US Food and Drug Administration (FDA) has designated Baxter’s recall of the Q-Link 13 mobile lift component a Class I, the most severe category indicating risk of serious injury or death.

As detailed in the agency’s July 23 announcement, the optional component connects to sling bars on several Baxter mobile lift systems, including the Uno 102 EE, Viking series (XS through XL), LikoLight, and related LikoScale adapter kits. The recall was reportedly initiated because the Q-Link 13 can allow a false latching of the Quick-Release Hook used on sling bars and other accessories, posing a risk of patient falls and injury. Baxter reported three serious injuries and one death linked to this failure.

According to FDA, Baxter issued two Urgent Product Recall letters—on May 30, 2025, to healthcare providers and on June 2, 2025, to home patients. Recommended actions include immediately discontinuing use of Q-Link 13 components, posting recall notices near affected equipment, and awaiting instructions for receiving a replacement Q-Link Mobile component designed to reduce risks. Full details and contact information are available in the complete announcement.